Form 4: Amedisys Inc. Executive Acquires Shares Through Restricted Stock Units
SEC Form 4
Jennifer G. Griffin, Chief Legal Officer of Amedisys Inc., reports the acquisition of 5,832 shares of common stock through restricted stock units (RSUs) and a change in indirect ownership via a 401(k) plan.
Summary
- On February 16, 2025, Jennifer G. Griffin, Chief Legal Officer of Amedisys Inc., acquired 5,832 shares of common stock through time-based RSUs.
- These RSUs will vest in installments: 25% on February 16, 2026, 25% on February 16, 2027, and 50% on February 16, 2028, contingent upon continuous employment with Amedisys.
- Following this transaction, Griffin directly owns 19,832 shares of Amedisys Inc.
- Griffin also reported indirect ownership of 341 shares through a 401(k) plan, based on a statement dated December 31, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions. The acquisition of shares by an executive is generally viewed as a positive sign, but it's not a major event.
Positives
- The acquisition of shares by a high-ranking officer could be interpreted as a positive signal about the company's future prospects.
Future Outlook
The vesting schedule of the RSUs indicates a multi-year commitment from the executive to remain with the company.
Industry Context
Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future performance within the healthcare services industry.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in the healthcare industry, with companies like UnitedHealth Group, CVS Health, and Humana also subject to similar scrutiny regarding executive stock ownership.
- The vesting schedule of the RSUs is a typical incentive structure used to retain key personnel, aligning their interests with the long-term performance of the company, similar to practices observed at LHC Group and Encompass Health.
Stakeholder Impact
- Shareholders may view the executive's increased stake in the company positively.
- Employees may see it as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| December 31, 2024 | Date of the 401(k) plan statement used for reporting indirect ownership. |
| February 16, 2025 | Date of the transaction where RSUs were awarded. |
| February 16, 2026 | First vesting date for 25% of the RSUs. |
| February 16, 2027 | Second vesting date for 25% of the RSUs. |
| February 16, 2028 | Final vesting date for 50% of the RSUs. |
| February 19, 2025 | Date of signature on the Form 4 filing. |
Keywords
Amedisys, AMED, Insider Trading, Form 4, RSU, Restricted Stock Units, Jennifer G. Griffin, Chief Legal Officer, Beneficial Ownership, 401(k)
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.